<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://vitalspanwire.com/news/pedf-peptides-head-neck-cancer-cell-study</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-28T21:02:05.940Z</news:publication_date><news:title>PEDF peptides show preliminary activity in head-and-neck cancer cells</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/nmn-trial-blood-nad-hearing-physical-function</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-28T16:02:39.180Z</news:publication_date><news:title>NMN trial raises blood NAD⁺ without significant hearing or physical-function gains</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/midlife-aging-marker-later-memory-lapses</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-28T11:02:08.747Z</news:publication_date><news:title>Midlife aging marker linked to later memory lapses in age-specific finding</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/cuhk-huntingtons-peptide-rp001v63-orphan-designation-development</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-27T21:01:49.606Z</news:publication_date><news:title>CUHK outlines development plans for Huntington’s peptide with FDA orphan designation</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/fda-approves-atebrioz-fibrodysplasia-ossificans-progressiva</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-27T16:02:06.228Z</news:publication_date><news:title>FDA approves Atebrioz for rare disease that forms bone in soft tissues</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/menopause-blood-proteins-cognitive-aging-dementia-risk</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-09-27T11:04:04.100Z</news:publication_date><news:title>Menopause-linked blood proteins associated with cognitive aging and dementia risk</news:title></news:news></url></urlset>